Tag: Risk benefit analysis

In 2021, about 60% of adults reported taking at least one prescription medication, with 36% taking three or more [1.2.3]. This widespread use raises a critical question: when it comes to pharmacology, **do drugs good or bad**? The answer lies in a careful balance of benefit and risk.

According to the European Medicines Agency (EMA), pharmacovigilance documents like PSUR and ICSR are fundamental to monitoring drug safety throughout its lifecycle. This article clarifies **what is the difference between PSUR and ICSR**, detailing their distinct roles and purposes in safeguarding public health.